Defense Health Research Consortium to Congress: Enact the FY24 Defense Appropriations Act
November 9, 2023
131 Patient Advocacy Organizations Call for Full Funding for Congressionally Directed Medical Research Programs (CDMRP)
The Defense Health Research Consortium and dozens of its affiliated members sent a letter to House and Senate leadership, calling on them to “work toward the enactment of the fiscal year 2024 Defense Appropriations Act, to ensure full funding levels for the Defense Health Research Programs, including the Congressionally Directed Medical Research Programs (CDMRP).”
The letter, signed by 131 patient advocacy organizations, health and medical associations, veterans organizations and colleges and universities, expresses concerns “about the possibility of Congress enacting additional short-term continuing resolutions that would delay final consideration of the appropriations bills until next year.” The letter also expresses even more serious concerns about a government shutdown which “would completely halt all operations of CDMRP and be highly disruptive to plans for soliciting, reviewing and evaluating grant applications and administering existing awards.”
The Defense Health Research Consortium was founded by CRD Associates to bring a diverse community together to advocate for the CDMRP, a $1.5 billion medical research program designed to meet the unique health and medical challenges of the men and women in the U.S. Armed Services. Funding for the CDMRP is added every year by Congress to the annual Defense Appropriations Act, and this funding has faced threats and similar challenges in previous years.
For more information about how CRD Associates can help your organization make a difference through CDMRP, please reach out to Mark Vieth at [email protected].